NCT06778421View on ClinicalTrials.gov

Impact of OnabotulinumtoxinA (BOTOX®) on Stress

PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 20, 2025

Primary Completion Date

July 31, 2025

Study Completion Date

September 30, 2025

Conditions
Stress (Psychology)StressHealthy Adult Female ParticipantsStress, PsychologicStress, Psychological CumulativeStress, PhysiologicalStress ResponseStress LevelsStress Perception
Interventions
PROCEDURE

Intramuscular injection

Injection performed using method for aesthetic facial rejuvenation procedure with neuromuscular chemodenervation agents

DRUG

OnabotulinumtoxinA (Botox®) Injections

"Injection of 64 units of active drug at a ratio of 4 units to 0.1 mL of sterile, preservative-free 0.9% Sodium Chloride Injection, United States Pharmacopeia (USP) Only~\- Abbvie/Allergan drug."

OTHER

Sodium Chloride

Placebo injection of the same volume of preservative-free 0.9% Sodium Chloride Injection, United States Pharmacopeia (USP) Only.

Trial Locations (1)

90212-2913

RECRUITING

Center for Advanced Facial Plastic Surgery, Beverly Hills

All Listed Sponsors
lead

Center for Advanced Facial Plastic Surgery

OTHER